Literature DB >> 24532490

Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.

L T Warris1, M M van den Heuvel-Eibrink, M A H den Hoed, F K Aarsen, R Pieters, E L T van den Akker.   

Abstract

Steroid-induced neuropsychological side effects impact quality of life in children with acute lymphoblastic leukemia. Dexamethasone induces more metabolic side effects than prednisone. To evaluate whether dexamethasone also leads to more neuropsychological side effects, we reviewed all available literature. Randomized controlled trials with neuropsychological function as the primary or secondary outcome did not show clinically meaningful differences between dexamethasone and prednisone on cognition, mood or behavior.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute lymphoblastic leukemia; corticosteroids; neuropsychological; pediatrics; psychological

Mesh:

Substances:

Year:  2014        PMID: 24532490     DOI: 10.1002/pbc.24988

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

1.  Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.

Authors:  Yin Ting Cheung; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2015-04-07       Impact factor: 8.989

2.  The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.

Authors:  Lauren C Daniel; Yimei Li; Jacqueline D Kloss; Anne F Reilly; Lamia P Barakat
Journal:  Support Care Cancer       Date:  2016-04-23       Impact factor: 3.603

3.  Brain Network Connectivity and Executive Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.

Authors:  Shelli R Kesler; Robert Ogg; Wilburn E Reddick; Nicholas Phillips; Matthew Scoggins; John O Glass; Yin Ting Cheung; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Brain Connect       Date:  2018-08

4.  Psycho-Behavioural Changes in Dogs Treated with Corticosteroids: A Clinical Behaviour Perspective.

Authors:  Lorella Notari; Roxane Kirton; Daniel S Mills
Journal:  Animals (Basel)       Date:  2022-02-26       Impact factor: 2.752

Review 5.  COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.

Authors:  Xueqing Wang; Yuanfang Guan
Journal:  Med Res Rev       Date:  2020-08-30       Impact factor: 12.944

6.  Effects of chemotherapy for acute lymphoblastic leukemia on cognitive function in animal models of contemporary protocols: A systematic literature review.

Authors:  Tyler C Alexander; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2021-08-03       Impact factor: 9.052

7.  Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549).

Authors:  Cody P Coyne; Lakshmi Narayanan
Journal:  Drug Des Devel Ther       Date:  2016-08-12       Impact factor: 4.162

8.  Root Extract of Polygonum cuspidatum Siebold & Zucc. Ameliorates DSS-Induced Ulcerative Colitis by Affecting NF-kappaB Signaling Pathway in a Mouse Model via Synergistic Effects of Polydatin, Resveratrol, and Emodin.

Authors:  Baohai Liu; Shuangdi Li; Xiaodan Sui; Lianyi Guo; Xingmei Liu; Hongmei Li; Leming Gao; Shusheng Cai; Yanrong Li; Tingting Wang; Xuehua Piao
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810

9.  The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.

Authors:  L M H Steur; G J L Kaspers; E J W van Someren; N K A van Eijkelenburg; I M van der Sluis; N Dors; C van den Bos; W J E Tissing; M A Grootenhuis; R R L van Litsenburg
Journal:  Support Care Cancer       Date:  2020-04-13       Impact factor: 3.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.